Table 2.
Demographic characteristics
| Variable | Glepaglutide dose group | ||
|---|---|---|---|
| SC 5 mg once weekly | SC 10 mg once weekly | IV 1 mg single dose | |
| Age (years), mean (SD) | 37 (12) | 42 (12) | 40 (11) |
| Sex, n (%) | |||
| Male | 7 (47) | 10 (67) | 10 (67) |
| Female | 8 (53) | 5 (33) | 5 (33) |
| Race, n (%) | |||
| Black or African American | 5 (33) | 4 (27) | 7 (47) |
| White | 10 (67) | 10 (67) | 8 (53) |
| Multiple | – | 1 (7) | – |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 2 (13) | 4 (27) | 4 (27) |
| Not Hispanic or Latino | 13 (87) | 11 (73) | 11 (73) |
| Weight (kg), mean (SD) | 76.4 (11.6) | 78.8 (10.8) | 74.8 (8.2) |
| BMI (kg/m2), mean (SD) | 26.2 (2.4) | 26.6 (2.4) | 26.2 (1.8) |
BMI body mass index, IV intravenous, SC subcutaneous, SD standard deviation